Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 β-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 17, 2009, Pages 4929-4932

  Maresca, Alfonso ^a   Carta, Fabrizio ^a   Vullo, Daniela ^a   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase; Mycobacterium tuberculosis; Prontosil; Rv1284; Rv3273; Sulfonamide; Sulfonate

Indexed keywords

AMINE; BENZENESULFONAMIDE DERIVATIVE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; DIAZENYLBENZENESULFONAMIDE DERIVATIVE; PHENOL DERIVATIVE; SULFAMIDOCHRYSOIDINE; SULFANILAMIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; DIAZOTIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTI-BACTERIAL AGENTS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 68349128339     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.07.088     Document Type: Article

References (38)

1. Dye C. Nat. Rev. Microbiol. 7 (2009) 81
2. Ginsberg A.M. Semin. Respir. Crit. Care Med. 29 (2008) 552
3. Showalter H.D., and Denny W.A. Tuberculosis (Edinb) 88 (2008) S3
4. Tomioka H., Tatano Y., Yasumoto K., and Shimizu T. Exp. Rev. Resp. Med. 2 (2008) 455
5. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Nature 393 (1998) 537
6. Suarez Covarrubias A., Larsson A.M., Hogbom M., Lindberg J., Bergfors T., Bjorkelid C., Mowbray S.L., Unge T., and Jones T.A. J. Biol. Chem. 280 (2005) 18782
7. Suarez Covarrubias A., Larsson A.M., Hogbom M., Lindberg J., Bergfors T., Bjorkelid C., Mowbray S.L., Unge T., and Jones T.A. J. Biol. Chem. 281 (2006) 4993
8. Nishimori I., Minakuchi T., Vullo D., Scozzafava A., Innocenti A., and Supuran C.T. J. Med. Chem. 52 (2009) 3116
9. Minakuchi T., Nishimori I., Vullo D., Scozzafava A., and Supuran C.T. J. Med. Chem. 52 (2009) 2226
10. Guzel O., Maresca A., Scozzafava A., Salman A., Balaban A.T., and Supuran C.T. J. Med. Chem. 52 (2009) 4063
11. Supuran C.T. Nat. Rev. Drug Disc. 7 (2008) 168
12. Innocenti A., Mühlschlegel F.A., Hall R.A., Steegborn C., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 18 (2008) 5066
13. Innocenti A., Hall R.A., Schlicker C., Mühlschlegel F.A., and Supuran C.T. Bioorg. Med. Chem. 17 (2009) 2654
14. Innocenti A., Hall R.A., Schlicker C., Scozzafava A., Steegborn C., Mühlschlegel F.A., and Supuran C.T. Bioorg. Med. Chem. 17 (2009) 4503
15. Innocenti A., Leewattanapasuk W., Mühlschlegel F.A., Mastrolorenzo A., and Supuran C.T. Bioorg. Med. Chem. Lett. 19 (2009) 4802
16. Schlicker C., Hall R.A., Vullo D., Middelhaufe S., Gertz M., Supuran C.T., Mühlschlegel F.A., and Steegborn C. J. Mol. Biol. 385 (2009) 1207
17. Innocenti A., Winum J.-Y., Hall R.A., Mühlschlegel F.A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 19 (2009) 2642
18. Nishimori I., Minakuchi T., Kohsaki T., Onishi S., Takeuchi H., Vullo D., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 3585
19. Bennett J.E., Izumikawa K., and Marr K.A. Antimicrob. Agents Chemother. 48 (2004) 1773
20. Fidel P.L.Jr., Vazquez J.A., and Sobel J.D. Clin. Microbiol. Rev. 12 (1999) 80
21. Tsai H.F., Krol A.A., Sarti K.E., and Bennett J.E. Antimicrob. Agents Chemother. 50 (2006) 1384
22. Hanage W.P., Fraser C., Tang J., Connor T.R., and Corander J. Science 324 (2009) 1454
23. Pai M., Turpin R., and Garey K. Antimicrob. Agents Chemother. 51 (2007) 35
24. Supuran C.T., Scozzafava A., and Conway J. Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton, New York, London p 1-363
25. Supuran C.T., Scozzafava A., and Casini A. Development of Sulfonamide Carbonic Anhydrase Inhibitors. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic anhydrase-Its inhibitors and activators (2004), CRC Press, Boca Raton 67-147
26. Supuran C.T. Carbonic Anhydrases as Drug Targets-General Presentation. In: Supuran C.T., and Winum J.Y. (Eds). Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications (2009), Wiley, Hoboken 15-38
27. Sassetti C.M., Boyd D.H., and Rubin E.J. Mol. Microbiol. 48 (2003) 77
28. Betts J.C., Lukey P.T., Robb L.C., McAdam R.A., and Duncan K. Mol. Microbiol. 43 (2002) 717
29. Miltner E., Daroogheh K., Mehta P.K., Cirillo S.L., Cirillo J.D., and Bermudez L.E. Infect. Immun. 73 (2005) 4214
30. Carta F., Pothen B., Maresca A., Tiwari M., Singh V., and Supuran C.T. Chem. Biol. Drug Des. 74 (2009) 196
31. Mandell G.L., and Petri Jr. W.A. Antimicrobial Agents. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Goodman and Gilman A. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (1996), McGraw-Hill, New York 1057-1072
32. Domagk G. Dtsch. Med. Wocheschr. 61 (1935) 250
33. Buttle G.A.H., Gray W.H., and Stephenson D. Lancet 1 (1936) 1286
34. Colebrook L., and Kenny H. Lancet 1 (1936) 1279
35. Mandell G.L., and Petri Jr. W.A. Drugs used in the Chemotherapy of Tuberculosis, Mycocatreium avium Complex Disease and Leprosy. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Goodman Gilman A. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. (1996), McGraw-Hill, New York 1155-1174
36. 3).
37. Briganti F., Pierattelli R., Scozzafava A., and Supuran C.T. Eur. J. Med. Chem. 31 (1996) 1001
38. 7-9